Latest News for: antibodies

Edit

New computational model can predict antibody structures more accurately

Phys Dot Org 02 Jan 2025
However, this approach hasn't been as successful for antibodies, ...
Edit

iBio Expands Cardiometabolic and Obesity Program with Anti Myostatin Antibody Discovered Using its Proprietary Platform, In Licensed from AstralBio Form 8 K (iBio Inc)

Public Technologies 02 Jan 2025
iBio Expands Cardiometabolic and Obesity Program with Anti-Myostatin Antibody Discovered Using its Proprietary Platform, In-Licensed from AstralBio ... IBIO), an AI-driven innovator of precision antibody ...
Edit

People who are immunocompromised may not produce enough protective antibodies against RSV after vaccination

Science Daily 30 Dec 2024
Researchers have shown that people 60 years or older with weakened immunity do not respond as strongly to vaccines against the respiratory syncytial virus (RSV) as people in the same age group with normal immune function ... .
Edit

Dr.SHIVA™:Beyond Antibodies @CytoSolve® Systems Analysis of Immunity(3/21)

Bitchute 29 Dec 2024
Go to the source via the article link to view the video or lcik the video icon ....
Edit

Preliminary Results of Qilu Pharmaceutical's Phase Ia Study on GPRC5D/CD3-Targeting Bispecific Antibody QLS32015 Unveiled at ...

Rio Grande Sun 26 Dec 2024
JINAN, China, Dec. 25, 2024 /PRNewswire/ -- During the 66th Annual Meeting of the American Society of Hematology (ASH) held in San Diego from December 7 to 10, preliminary results from the first human trial of QLS32015, a novel anticancer ... .
Edit

Preliminary Results of Qilu Pharmaceutical's Phase Ia Study on GPRC5D/CD3-Targeting Bispecific Antibody QLS32015 Unveiled at 2024 ASH Annual Meeting

PR Newswire 25 Dec 2024
QLS32015, a novel humanized IgG1 T-cell retargeting bispecific antibody, targets both GPRC5D, a G protein-coupled receptor class C group 5 member D, and CD3 ... and anti-CD38 monoclonal antibodies.
Edit

Creative Biolabs Accomplished Their Exhibition at Antibody Engineering & Therapeutics (US) 2024

GetNews 24 Dec 2024
New York, USA - December 24, 2024 - "Bringing together a lively community of experts and innovators," a delegate from Creative Biolabs says, "this is one of the most prestigious antibody-related events we've ever been engaged in.".
Edit

RAPT Therapeutics And Shanghai Jemincare Pharmaceutical Announce Exclusive License Agreement For Novel Long-Acting Anti-Ige Antibody

MENA FN 23 Dec 2024
(MENAFN - GlobeNewsWire - Nasdaq) - RAPT obtains worldwide rights excluding China - - Jemincare receives $35 million upfront payment, up to $672.5 million in milestone payments and high ... .

Most Viewed

×